SPOTLIGHT -
The elements of workplace leadership that have been forgotten in a digital age.
Medicare Advantage, Racing Along, Hits Some Speed Bumps
Enrollment has soared, but a relatively modest 2025 rate increase and changes to the Star rating system may lead plans to cut back on with their benefit offerings.
Read More
Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics
This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company.
Listen
As Data Pile Up, Some Healthcare Organizations Turn To ‘Lakehouses’
Healthcare organizations generate and store vast amounts of data but they often have to choose between speed and structure. Data "lakehouses" may be the answer.
DC Roundtable Video: Patrick Cooney on PBM Legislation in Washington
Daratumumab Therapy Effective for Newly Diagnosed High-Risk Multiple Myeloma
Darzalex (daratumumab) is a monoclonal antibody drug currently approved for both refractory and new multiple myeloma. It’s available in intravenous and subcutaneous formulations.
IQVIA: Medicine Spending Expected to Grow 4% to 7%
Over the next five years, list prices of protected prescription drugs are expected grow between 1% and 4% a year, while net prices are expected to decline by the same amount, IQVIA predicts.